Browse > Article
http://dx.doi.org/10.5487/TR.2010.26.3.193

Inhibitory Effect of 1-O-Hexyl-2,3,5-Trimethylhydroquinone on Dimethylnitrosamine-induced Liver Fibrosis in Male SD Rats  

Jung, Yu-Ri (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
Lee, Young-Jung (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
Lee, Nam-Jin (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
Lin, Chun-Mai (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
Moon, Jun-Hawn (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
Chai, Hee-Yul (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
Kang, Jong-Koo (College of Veterinary Medicine and Research Institute of Veterinary Medicine, Chungbuk National University)
Publication Information
Toxicological Research / v.26, no.3, 2010 , pp. 193-201 More about this Journal
Abstract
Hepatic fibrosis represents the main complication of most chronic liver disorders and, regardless of its etiology, is characterized by excessive deposition of extracellular matrix components. In this study, we examined that 1-O-Hexyl-2,3,5-Trimethylhydroquinone (HTHQ), a potent anti-oxidative agent, could prevent experimental hepatic fibrosis induced by dimethylnitrosamine (DMN) in male SD rats. Except for vehicle control group, other groups were induced hepatic fibrosis by intraperitoneal injection with DMN (10 mg/ml/kg) on 3 consecutive days weekly for 4 weeks. During the same 4 weeks, control and DMN groups were given vehicle and HTHQ 50, 100 and 200 groups were orally administered HTHQ (50, 100, 200 mg/kg respectively). In HTHQ 100 and 200 groups, relative liver weight and serum chemistry level improved significantly. HTHQ reduced hydroxyproline (p < 0.05) and malondialdehyde (p < 0.05) level in the liver. Histopathological examination of H&E, Masson's trichrome stain showed the reduced fibrotic septa in HTHQ 100 and 200 groups. HTHQ administration showed reduced mRNA level of PDGF (Platelet-derived growth factor), $\alpha$-SMA ($\alpha$-smooth muscle actin) and TGF-$\beta$ (transforming growth factor-$\beta$) than DMN-induced hepetic fibrosis animals in the liver tissue. In this study, we showed that HTHQ improves against DMN-induced liver fibrosis in male SD rats.
Keywords
HTHQ; DMN; Hepatic fibrosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Shiba, M., Shimizu, I., Yasuda, M., Ii, K. and Ito, S. (1998).Expression of type I and type III collagens during the course ofdimethylnitrosamine-induced hepatic fibrosis in rats. Liver, 18,196-204.
2 Shimizu, I., Mizobuchi, Y., Yasuda, M., Shiba, M., Ma, Y.R.,Horie, T., Liu, F. and Ito, S. (1999). Inhibitory effect of oestradiol on activation of rat hepatic stellate cells in vivo and in vitro. Gut, 44, 127-136.   DOI
3 Strain, A. and Anna, M.D. (1998). Liver Growth and Repair,Chapman & Hall, London.
4 Trump, B.F. and Berezesky, I.K. (1992). The role of cytosolicCa2+ in cell injury, necrosis and apoptosis. Curr. Opin. Cell Biol., 4, 227-232.
5 Li, B.L., Zhao, X.X., Liu, X.Y., Kim, H.S., Raska, K., Jr., Ortaldo,J.R., Schwartz, B. and Pestka, S. (1990). Alpha-interferon structure and natural killer cell stimulatory activity. Cancer Res., 50, 5328-5332.
6 Luckey, S.W. and Petersen, D.R. (2001). Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp. Mol. Pathol., 71, 226-240.   DOI   ScienceOn
7 Magee, P.N. and Barnes, J.M. (1967). Carcinogenic nitroso compounds. Adv. Cancer Res., 10, 163-246.   DOI
8 Mancuso, C., Pani, G. and Calabrese, V. (2006). Bilirubin: anendogenous scavenger of nitric oxide and reactive nitrogen species. Redox Rep., 11, 207-213.   DOI
9 Marra, F., Gentilini, A., Pinzani, M., Choudhury, G.G., Parola, M., Herbst, H., Dianzani, M.U., Laffi, G., Abboud, H.E. and Gentilini,P. (1997). Phosphatidylinositol 3-kinase is required for platelet-derived growth factor’s actions on hepatic stellate cells. Gastroenterology, 112, 1297-1306.   DOI   ScienceOn
10 Maton, A., Hopkins J., McLaughlin, C.W., Johnson, S., Warner,M.Q., LaHart, D. and Wright, J.D. (1993). Human Biology andHealth. Englewood Cliffs, New Jersey, USA: Prentice Hall.
11 McGavin, M.D. and Zachary, J.F. (2007). Pathologic basis of veterinary disease, Elsevier Mosby, St.Louis.
12 Nihro, Y., Furukawa, H., Sogawa, S., Wang, T.C., Miyataka, H., Matsumoto, H., Miki, T. and Satoh, T. (1994). Synthesis and anti lipid-peroxidation activity of hydroquinone monoalkyl ethers. Chem. Pharm. Bull. (Tokyo), 42, 576-579.   DOI   ScienceOn
13 Pinzani, M., Marra, F. and Carloni, V. (1998). Signal transduction in hepatic stellate cells. Liver, 18, 2-13.
14 Saile, B., Matthes, N., Knittel, T. and Ramadori, G. (1999). Transforming growth factor beta and tumor necrosis factor alphainhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology, 30, 196-202.   DOI
15 Hirose, M., Akagi, K., Hasegawa, R., Yaono, M., Satoh, T., Hara,Y., Wakabayashi, K. and Ito, N. (1995a). Chemoprevention of2-amino-1-methyl-6-phenylimidazo[4,5-b]-pyridine (PhIP)-induced mammary gland carcinogenesis by antioxidants inF344 female rats. Carcinogenesis, 16, 217-221.   DOI
16 Hirose, M., Hasegawa, R., Kimura, J., Akagi, K., Yoshida, Y.,Tanaka, H., Miki, T., Satoh, T., Wakabayashi, K., Ito, N. andShirai, T. (1995b). Inhibitory effects of 1-O-hexyl-2,3,5-trimethylhydroquinone (HTHQ), green tea catechins and other antioxidants on 2-amino-6-methyldipyrido[1,2-a:3',2'-d]imidazole(Glu-P-1)-induced rat hepatocarcinogenesis and dose-dependentinhibition by HTHQ of lesion induction by Glu-P-1 or 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx). Carcinogenesis,16, 3049-3055.   DOI   ScienceOn
17 Lang, A., Schoonhoven, R., Tuvia, S., Brenner, D.A. and Rippe,R.A. (2000). Nuclear factor kappaB in proliferation, activation,and apoptosis in rat hepatic stellate cells. J. Hepatol., 33, 49-58.   DOI   ScienceOn
18 Hirose, M., Ito, T., Takahashi, S., Ozaki, M., Ogiso, T., Nihro, Y.,Miki, T. and Shirai, T. (1998). Prevention by synthetic phenolic antioxidants of 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx)- or activated MeIQx-induced mutagenesis and MeIQx-induced rat hepatocarcinogenesis, and role of antioxidant activity in the prevention of carcinogenesis. Eur. J. Cancer Prev., 7, 233-241.   DOI
19 Hirose, M., Iwata, S., Ito, E., Nihro, Y., Takahashi, S., Mizoguchi,Y., Miki, T., Satoh, T., Ito, N. and Shirai, T. (1995c). Strong anti-mutagenic activity of the novel lipophilic antioxidant 1-Ohexyl-2,3,5-trimethylhydroquinone against heterocyclic amineinduced mutagenesis in the Ames assay and its effect on metabolic activation of 2-amino-6-methyldipyrido[1,2-a:3',2'-d] imidazole (Glu-p-1). Carcinogenesis, 16, 2227-2232.   DOI
20 Jezequel, A.M., Mancini, R., Rinaldesi, M.L., Ballardini, G., Fallani, M., Bianchi, F. and Orlandi, F. (1989). Dimethylnitrosamine-induced cirrhosis. Evidence for an immunological mechanism. J. Hepatol., 8, 42-52.   DOI
21 Edwards, C.K., 3rd, Myers, M.J., Kelley, K.W. and Schook, L.B.(1991). Enhanced macrophage anti-microbial activity followingdimethylnitrosamine exposure in vivo is related to augmentedproduction of reactive oxygen metabolites. Immunopharmacol.Immunotoxicol., 13, 395-411.   DOI
22 Elsharkawy, A.M., Wright, M.C., Hay, R.T., Arthur, M.J., Hughes,T., Bahr, M.J., Degitz, K. and Mann, D.A. (1999). Persistentactivation of nuclear factor-kappaB in cultured rat hepatic stellate cells involves the induction of potentially novel Rel-like factors and prolonged changes in the expression of IkappaBfamily proteins. Hepatology, 30, 761-769.   DOI
23 Friedman, S.L., Roll, F.J., Boyles, J. and Bissell, D.M. (1985).Hepatic lipocytes: the principal collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. USA, 82, 8681-8685.   DOI   ScienceOn
24 Farber, E. (1996). Orientation in Liver Toxicity by Drugs, Handbook of Experimental Pharmacology, Springer-Verlag, Berlin,Germany.
25 Friedman, S.L. (1990). Cellular sources of collagen and regulation of collagen production in liver. Semin. Liver Dis., 10, 20-29.   DOI   ScienceOn
26 Friedman, S.L. (2000). Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem., 275, 2247-2250.   DOI   ScienceOn
27 Gressner, A.M. and Bachem, M.G. (1990). Cellular sources ofnoncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin. Liver Dis., 10, 30-46.   DOI   ScienceOn
28 Haggerty, H.G. and Holsapple, M.P. (1990). Role of metabolism indimethylnitrosamine-induced immunosuppression: a review. Toxicology, 63, 1-23.   DOI   ScienceOn
29 Hashimoto, N., Ishikawa, Y. and Utsunomiya, J. (1989). Effects of portacaval shunt, transposition, and dimethylnitrosamine-induced chronic liver injury on pancreatic hormones and amino acids in dog. J. Surg. Res., 46, 35-40.   DOI   ScienceOn
30 Ahmed, A. and Keeffe, E.B. (2004). Chronic hepatitis C with normal aminotransferase levels. Gastroenterology, 126, 1409-1415.   DOI   ScienceOn
31 Baskol, G., Atmaca, H., Tanriverdi, F., Baskol, M., Kocer, D. and Bayram, F. (2007). Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp. Clin. Endocrinol. Diabetes, 115, 522-526.   DOI   ScienceOn
32 Bertelli, A.A., Giovannini, L., Stradi, R., Bertelli, A. and Tillement,J.P. (1996). Plasma, urine and tissue levels of trans- and cis-resveratrol (3,4',5-trihydroxystilbene) after short-term or prolonged administration of red wine to rats. Int. J. Tissue React., 18, 67-71.
33 Britton, R.S. and Bacon, B.R. (1994). Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology, 41, 343-348.
34 Cooksley, W.G., Bradbear, R.A., Robinson, W., Harrison, M., Halliday,J.W., Powell, L.W., Ng, H.S., Seah, C.S., Okuda, K.,Scheuer, P.J. and Sherlock, S. (1986). The prognosis of chronicactive hepatitis without cirrhosis in relation to bridging necrosis. Hepatology, 6, 345-348.   DOI